Table 1.

The 10 most cited papers in SBRT until 2021.

Rank	Title	Corresponding Author	Journal	Year	Total citations	Average citations per year (rank)
1	Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer	Timmerman	JAMA	2010	1688	146.78 (2)
2	Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer	Timmerman	J. Clin. Oncol.	2006	1009	67.64 (7)
3	Stereotactic body radiation therapy: The report of AAPM Task Group 101	Benedict	Med. Phys.	2010	949	85.62 (6)
4	Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials	Chang	Lancet Oncol.	2015	818	130.88 (4)
5	Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non-Small-Cell Lung Cancer Patients Treated with Stereotactic Body Radiotherapy	Baumann	J. Clin. Oncol.	2009	620	50.96 (12)
6	Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial	Palma	Lancet	2019	588	252 (1)
7	Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study	Fakiris	Int. J. Radiat. Oncol. Biol. Phys.	2009	577	48.76 (13)
8	Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases	Schefter a	J. Clin. Oncol.	2009	572	46.07 (14)
9	Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame	Nagata	Int. J. Radiat. Oncol. Biol. Phys.	2005	481	30.54 (30)
10	Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma	Bujold	J. Clin. Oncol.	2013	441	52.92 (10)

^aAll corresponding authors except Schefter were also first authors.